PD-L1 expression correlation with metabolic parameters of 18F FDG PET/CT in nonsmall cell lung cancer> Source: Virtual Congress 2021 – Pulmonary neoplasia and related pathologies Year: 2021
The role of Pgp, MRP and LRP expression in chemotherapy response of small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 78s Year: 2004
Correlation between standardised uptake value on PET scans, tumour characteristics and survival in resected lung cancer patients Source: Annual Congress 2007 - Prognosis and diagnosis of thoracic malignancies Year: 2007
Changes in the expression of Glutathione S Transferase-π (GST-π) and P-glycoprotein (P-gp) in bronchoscopic specimen of patients with lung cancer before and after chemotherapy Source: Eur Respir J 2001; 18: Suppl. 33, 231s Year: 2001
Prognostic value of primary tumour maximum standardized uptake value (SUV max) in non small cell lung cancer (NSCLC) with F18-fluorodeoxyglucose positron emission tomography (FDG-PET): a systematic review and meta-analysis (MA) by the European Lung Cancer Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology Year: 2007
Integrated 18 F – FDG PET dynamic contrast enhanced CT to phenotype non-small cell lung cancer Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011
18F-FDG PET scans demonstrate strong correlation between spleen metabolism and serum IL-2R levels in patients with untreated sarcoidosis under surveillance Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked Year: 2013
Comparison of CT and PET in detection of lung metastases Source: Annual Congress 2004 - Lung cancer: epidemiology, diagnosis, staging Year: 2004
Correlation of P53 and CerbB-2 expression in the diagnostic biopsies and the corresponding resected tumors in non small cell lung caner Source: Eur Respir J 2004; 24: Suppl. 48, 43s Year: 2004
Utility of 18 FDG-PET scan in stage 1a non small cell lung cancer (NSCLC) Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009
Scintigraphy with 99m Tc-depreotide has a high sensitivity in detecting lung cancer Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques Year: 2007
Correlation of p53, EGFR and HER2 expression in the diagnostic biopsies and the corresponding resected tumours in NSCLC Source: Eur Respir J 2003; 22: Suppl. 45, 198s Year: 2003
Role of Tc-99m MIBI chest SPECT to detect mediastinal lymph node metastasis in patients with non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 314s Year: 2005
Prognostic impact of FDG-PET in recurrence of surgically treated non-small cell lung cancer Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005
Synchronous primary malignancies identified during staging 18F-FDG PET scan in lung cancer patients Source: Annual Congress 2010 - Staging of lung cancer Year: 2010
Relationship between a clinical drug resistance and immunohistochemical expression of P-glycoprotien, multidrug resistance protein, and p53 in small cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 231s Year: 2002
In vivo growth of 60 non-screening detected lung cancers: a computed tomography studySource: Eur Respir J, 51 (4) 1702183; 10.1183/13993003.02183-2017 Year: 2018
Strong correlation between 18F-FDG PET positive bone involvement and increased IL-2R levels in patients with untreated sarcoidosis under surveillance (Preliminary results) Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis Year: 2012
The effect of MRP1 variants and the intensity of MRP1 protein expression in bronchial biopsies on lung function decline in COPD Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010
Where next for lung cancer gene expression profiling? Source: Eur Respir J 2007; 30: 5-6 Year: 2007